Q3 2022

Filed Nov 8, 2022 · 10-Q · 39 days after period end · 0000877860-22-000073

Q3 2022 · 10-Q

Revenue

$12.01M

— vs Q3 2021

Net Income

$34.47M

+11.9% vs Q3 2021

EPS Diluted

$0.78

+16.4% vs Q3 2021

Operating Cash Flowderived$43,535,000−11.1%

Same quarter

Metric	Q3 2022	Q3 2021	Q3 2020	Q3 2019
Revenue	$12.01M	$0.00	$84.30M	$81.68M
Net Income	$34.47M	$30.81M	$42.60M	$42.76M
EPS Diluted	$0.78	$0.67	$0.95	$0.97

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR